No Benefit With Hydrocortisone in Terms of Survival Without Bronchopulmonary Dysplasia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia
N. Engl. J. Med 2022 Mar 24;386(12)1121-1131, KL Watterberg, MC Walsh, L Li, S Chawla, CT D'Angio, RN Goldberg, SR Hintz, MM Laughon, BA Yoder, KA Kennedy, GE McDavid, C Backstrom-Lacy, A Das, MM Crawford, M Keszler, GM Sokol, BB Poindexter, N Ambalavanan, AM Hibbs, WE Truog, B Schmidt, MH Wyckoff, AM Khan, M Garg, PR Chess, AM Reynolds, M Moallem, EF Bell, LR Meyer, RM Patel, KP Van Meurs, CM Cotten, EC McGowan, AC Hines, S Merhar, M Peralta-Carcelen, DE Wilson-Costello, HW Kilbride, SB DeMauro, RJ Heyne, RA Mosquera, G Natarajan, IB Purdy, JR Lowe, NL Maitre, HM Harmon, LA Hogden, I Adams-Chapman, S Winter, WF Malcolm, RD HigginsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.